Frankfurt am Main, Germany

Hans Schleussner


Average Co-Inventor Count = 3.2

ph-index = 7

Forward Citations = 176(Granted Patents)


Company Filing History:


Years Active: 1983-1990

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovations of Hans Schleussner

Introduction

Hans Schleussner is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of medical technology, particularly in the area of plasma treatment and immunoglobulin preparation. With a total of 8 patents to his name, Schleussner's work has had a profound impact on the safety and efficacy of blood products.

Latest Patents

Among his latest patents is a method of sterilizing plasma or plasma fractions. This method includes the treatment of plasma containing the blood-coagulating Factor VIII with beta-propiolactone or ultraviolet radiation. Additionally, treatment with tri-n-butyl phosphate and sodium cholate or Tween 80 is performed either prior to or simultaneously with the sterilization process. Another significant patent involves a method of producing a virus-safe, storage-stable, and intravenously tolerable immunoglobulin-G preparation. This method aims to make industrial-scale production economical through the enrichment and multistage purification of plasma that has had coagulation factors removed. The process includes the use of ion exchangers and ultrafiltration, ensuring the resulting immunoglobulin-G solution is both stable and safe for use.

Career Highlights

Schleussner has worked with reputable companies such as Biotest Serum Institut GmbH and Biotest Pharma GmbH. His experience in these organizations has allowed him to develop and refine his innovative methods in plasma treatment and immunoglobulin preparation.

Collaborations

Throughout his career, Hans Schleussner has collaborated with esteemed colleagues, including Herbert Dichtelmuller and Wolfgang Stephan. These partnerships have contributed to the advancement of his research and the successful implementation of his patented methods.

Conclusion

Hans Schleussner's contributions to medical technology through his patents and collaborations have significantly enhanced the safety and effectiveness of blood products. His innovative methods continue to influence the field and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…